Javascript must be enabled to continue!
Generation Using Phage-Display of pH-Dependent Antibodies Against the Tumor-Associated Antigen AXL
View through CrossRef
Background/Objectives: Tumor-associated antigens are not tumor-specific antigens but proteins that are overexpressed by tumor cells and also weakly expressed at the surface of healthy tissues. Therefore, some side effects are observed when targeted by therapeutic antibodies, a phenomenon named “on-target, off-tumor toxicity”. As tumors generate an acidic microenvironment, we investigated whether we could generate pH-dependent antibodies to increase their tumor specificity. For this proof-of-concept study, we selected the tyrosine kinase receptor AXL because we already developed several antibodies against this target. Methods: To generate a pH-dependent anti-AXL antibody, we performed classical panning of a single-chain variable fragment (scFv) library using phage display at an acidic pH throughout the process. Results: After the third round of panning, 9 scFvs, among the 96 picked clones, bound to AXL at acidic pH and showed very low binding at a neutral pH. After reformatting them into IgG, two clones were selected for further study due to their strong pH-sensitive binding. Using molecular docking and alanine scanning, we found that their binding strongly depended on two histidine residues present on AXL at positions 61 and 116. Conclusions: To conclude, we set-up an easy process to generate pH-dependent antibodies that may increase their tumor-binding specificity and potentially decrease toxicity towards healthy tissues.
MDPI AG
Title: Generation Using Phage-Display of pH-Dependent Antibodies Against the Tumor-Associated Antigen AXL
Description:
Background/Objectives: Tumor-associated antigens are not tumor-specific antigens but proteins that are overexpressed by tumor cells and also weakly expressed at the surface of healthy tissues.
Therefore, some side effects are observed when targeted by therapeutic antibodies, a phenomenon named “on-target, off-tumor toxicity”.
As tumors generate an acidic microenvironment, we investigated whether we could generate pH-dependent antibodies to increase their tumor specificity.
For this proof-of-concept study, we selected the tyrosine kinase receptor AXL because we already developed several antibodies against this target.
Methods: To generate a pH-dependent anti-AXL antibody, we performed classical panning of a single-chain variable fragment (scFv) library using phage display at an acidic pH throughout the process.
Results: After the third round of panning, 9 scFvs, among the 96 picked clones, bound to AXL at acidic pH and showed very low binding at a neutral pH.
After reformatting them into IgG, two clones were selected for further study due to their strong pH-sensitive binding.
Using molecular docking and alanine scanning, we found that their binding strongly depended on two histidine residues present on AXL at positions 61 and 116.
Conclusions: To conclude, we set-up an easy process to generate pH-dependent antibodies that may increase their tumor-binding specificity and potentially decrease toxicity towards healthy tissues.
Related Results
Abstract 406: Mechanism of AXL regulation in chemotherapy resistance
Abstract 406: Mechanism of AXL regulation in chemotherapy resistance
Abstract
Constitutive activation of receptor tyrosine kinase AXL is an important phenomenon in chemotherapy resistance and is highly expressed in several malignancie...
Axl, A Receptor Tyrosine Kinase, Mediates Flow-Induced Vascular Remodeling
Axl, A Receptor Tyrosine Kinase, Mediates Flow-Induced Vascular Remodeling
Intima-media thickening (IMT) in response to hemodynamic stress is a physiological process that requires coordinated signaling among endothelial, inflammatory, and vascular smooth ...
Phage in Display
Phage in Display
Abstract
Phage display is a process by which a peptide or a protein is expressed as an exterior fusion to a surface protein of a phage particle. The peptide or prote...
Paratope mapping of tilvestamab, an anti-AXL function blocking antibody, using high-throughput bacterial expression of secreted scFv-ompY fusion proteins
Paratope mapping of tilvestamab, an anti-AXL function blocking antibody, using high-throughput bacterial expression of secreted scFv-ompY fusion proteins
AbstractTargeting AXL with a highly selective antibody presents a promising approach for inhibiting AXL and potentially improving cancer treatment. An essential step in antibody op...
Abstract 3806: Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer
Abstract 3806: Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer
Abstract
Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) induce a dramatic response in non-small cell lung cancer (NSCLC) patients with the ALK fusi...
What makes a temperate phage an effective bacterial weapon?
What makes a temperate phage an effective bacterial weapon?
AbstractTemperate bacteriophages (phages) are common features of bacterial genomes and can act as self-amplifying biological weapons, killing susceptible competitors and thus incre...
Citrulline‐modified phage display: A novel high‐throughput discovery approach for the identification of citrulline‐containing ligands
Citrulline‐modified phage display: A novel high‐throughput discovery approach for the identification of citrulline‐containing ligands
AbstractPhage display is a high‐throughput technology used to identify ligands for a given target. A drawback of the approach is the absence of PTMs in phage‐displayed peptides. Th...
Structural analysis of tilvestamab in complex with AXL
Structural analysis of tilvestamab in complex with AXL
Abstract
AXL is a receptor tyrosine kinase with a significant role in various biological processes and important medical implications, particularly in cancer. AXL trans...

